ZInvestorHunting

Matthew Robert Kaeberlein

Solo GP · Port Washington, New York

Verified Active Check-WriterUS Angel

Named as one of two individuals (Managing Member of the General Partner and the Investment Manager) on the Form D for Vivace Longevity Fund I LP, a venture fund (Sep 2026). Also a non-executive director at 1 startup that filed Form D.

Investor IntelligenceVerified Activity

Angel Investment Confidence Score

Algorithmic score indicating recent deal velocity, check size reliability, and investment conviction in early-stage startups.

88/ 100
High Conviction Angel1 deals in last 12 months
Deal Velocity1 deals in last 12 monthsUSA & Europe pipeline
Typical CheckDisclosed on filePre-Seed / Seed
Primary FocusBiotech & PharmaPre-seed
Direct AccessWarm Intro Recommended1-click pitch match

Why Matthew Robert Kaeberlein holds a 88/100 confidence score

  • Verified active check-writing activity within the last 12 months
  • Active co-investor alongside leading venture syndicates
  • Clear domain thesis in Biotech & Pharma
  • Named as one of two individuals (Managing Member of the General Partner and the Investment Manager) on the Form D for Vivace Longevity Fund I LP, a venture fund (Sep 2026). Also a non-executive director at 1 startup that filed Form D.

Building in Biotech & Pharma? See how well your pitch deck matches Matthew Robert Kaeberlein’s thesis.

Check My Startup Fit

Verified investment track record

Named as one of two individuals (Managing Member of the General Partner and the Investment Manager) on the Form D for Vivace Longevity Fund I LP, a venture fund (Sep 2026). Also a non-executive director at 1 startup that filed Form D.

Source: SEC Form D: Vivace Longevity Fund I LP (Sep 24, 2026) · 1 more source

Stages
Pre-seed
Typical check (est.)
Disclosed on file
Verified deals
2 on file
Latest activity
Sep 2026
Pitch Readiness

Is Matthew Robert Kaeberlein a fit for you?

See your AI startup fit score, verified contact channels, and warm paths through your network.

What sectors does Matthew Robert Kaeberlein back?

Biotech & Pharma

Verified investments & deal activity

2 deals tracked

Recent startup investments, syndicate rounds, and public co-investments across the US and Europe.

  • Vivace Longevity Fund I LP

    Invested through a fund

    Sep 2026
  • Ora Biomedical

    Board seat on the company's SEC filing · WA

    Jan 2024

Public Verification Sources

Data refreshed from SEC filings and public European announcements Oct 15, 2026. Is this you? Correct or remove this profile.

Syndicate IntelligenceUSA & Europe

Active Angels Similar to Matthew Robert Kaeberlein

Founders raising in bio also reach out to these verified check-writers with similar portfolio focus and check sizes.

View all matching angels
Ben Horowitz

Solo GP · Menlo Park, CA

99/100
$75K–$200KActive Sep 2026
AI & MLBiotech & PharmaCrypto & Web3+1
Golden Seeds

Angel group · Scottsdale, AZ

97/100
$125K–$350KActive Oct 2026
HealthcareBiotech & PharmaConsumer+2
Paul Jun

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
Jeffrey Arnold

Solo GP · San Francisco, CA

88/100
Active Aug 2026
Biotech & Pharma
David Blivin

Solo GP · Santa Fe, NM

86/100
$800K–$2.4MActive Feb 2026
B2B SoftwareBiotech & PharmaClimate & Energy
Ziqiang Tang

Solo GP · Berkeley, CA

85/100
Active May 2026
Media, Gaming & CreatorSpaceBiotech & Pharma
AI Pitch & Angel Matcher

Raising pre-seed or seed for your startup?

Don’t pitch blindly. Our AI engine evaluates your startup against Matthew Robert Kaeberlein and 100+ active US & European angels to deliver 3 perfect matches with tailored warm intros and pitch deck reviews.